These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
725 related articles for article (PubMed ID: 30502719)
1. The ins and outs of type I iNKT cell development. Shissler SC; Webb TJ Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719 [TBL] [Abstract][Full Text] [Related]
2. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells. Gerth E; Mattner J Front Immunol; 2019; 10():1449. PubMed ID: 31293596 [TBL] [Abstract][Full Text] [Related]
3. Mutation of the Traj18 gene segment using TALENs to generate Natural Killer T cell deficient mice. Zhang J; Bedel R; Krovi SH; Tuttle KD; Zhang B; Gross J; Gapin L; Matsuda JL Sci Rep; 2016 Jun; 6():27375. PubMed ID: 27256918 [TBL] [Abstract][Full Text] [Related]
4. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control. Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y Front Immunol; 2018; 9():1266. PubMed ID: 29928278 [TBL] [Abstract][Full Text] [Related]
5. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens. Girardi E; Maricic I; Wang J; Mac TT; Iyer P; Kumar V; Zajonc DM Nat Immunol; 2012 Sep; 13(9):851-6. PubMed ID: 22820602 [TBL] [Abstract][Full Text] [Related]
6. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens. Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925 [TBL] [Abstract][Full Text] [Related]
7. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390 [TBL] [Abstract][Full Text] [Related]
8. The hypervariable region 4 (HV4) and position 93 of the α chain modulate CD1d-glycolipid binding of iNKT TCRs. Paletta D; Fichtner AS; Hahn AM; Starick L; Beyersdorf N; Monzon-Casanova E; Mueller TD; Herrmann T Eur J Immunol; 2015 Jul; 45(7):2122-33. PubMed ID: 25900449 [TBL] [Abstract][Full Text] [Related]
9. Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface. Brennan PJ; Cheng TY; Pellicci DG; Watts GFM; Veerapen N; Young DC; Rossjohn J; Besra GS; Godfrey DI; Brenner MB; Moody DB Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8348-8353. PubMed ID: 28716901 [TBL] [Abstract][Full Text] [Related]
10. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells. Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291 [TBL] [Abstract][Full Text] [Related]
11. Effective functional maturation of invariant natural killer T cells is constrained by negative selection and T-cell antigen receptor affinity. Bedel R; Berry R; Mallevaey T; Matsuda JL; Zhang J; Godfrey DI; Rossjohn J; Kappler JW; Marrack P; Gapin L Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E119-28. PubMed ID: 24344267 [TBL] [Abstract][Full Text] [Related]
12. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors. Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533 [TBL] [Abstract][Full Text] [Related]
13. Role of CD1d- and MR1-Restricted T Cells in Asthma. Iwamura C; Nakayama T Front Immunol; 2018; 9():1942. PubMed ID: 30210497 [TBL] [Abstract][Full Text] [Related]
14. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen. Patel O; Pellicci DG; Uldrich AP; Sullivan LC; Bhati M; McKnight M; Richardson SK; Howell AR; Mallevaey T; Zhang J; Bedel R; Besra GS; Brooks AG; Kjer-Nielsen L; McCluskey J; Porcelli SA; Gapin L; Rossjohn J; Godfrey DI Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19007-12. PubMed ID: 22065767 [TBL] [Abstract][Full Text] [Related]
15. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Wu L; Gabriel CL; Parekh VV; Van Kaer L Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798 [TBL] [Abstract][Full Text] [Related]
16. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells. East JE; Sun W; Webb TJ J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308 [TBL] [Abstract][Full Text] [Related]
17. Immunometabolic Activation of Invariant Natural Killer T Cells. Ververs FA; Kalkhoven E; Van't Land B; Boes M; Schipper HS Front Immunol; 2018; 9():1192. PubMed ID: 29892305 [TBL] [Abstract][Full Text] [Related]
18. Critical role for invariant chain in CD1d-mediated selection and maturation of Vα14-invariant NKT cells. Sillé FC; Martin C; Jayaraman P; Rothchild A; Besra GS; Behar SM; Boes M Immunol Lett; 2011 Sep; 139(1-2):33-41. PubMed ID: 21565221 [TBL] [Abstract][Full Text] [Related]
19. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells. Lawson V Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667 [TBL] [Abstract][Full Text] [Related]
20. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1. Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]